These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 10549093

  • 21. A comparison of two dose regimens in pancreatic cancer.
    Figer A, Sadikov E, Mishaeli M, Koren R, Gal R, Levin I, Klein B.
    J Chemother; 2000 Oct; 12(5):442-5. PubMed ID: 11128566
    [Abstract] [Full Text] [Related]

  • 22. Concomitant radiotherapy with protracted 5-fluorouracil infusion in locally advanced carcinoma of the pancreas: a phase II study.
    Osti MF, Costa AM, Bianciardi F, De Nicolò M, Donato V, Silecchia G, Enrici RM.
    Tumori; 2001 Oct; 87(6):398-401. PubMed ID: 11989594
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Phase II study of repeated single 24-hour infusion of low-dose 5-fluorouracil for palliation in symptomatic hormone-refractory prostate cancer.
    Bex A, Otto T, Lümmen G, Rübben H.
    Urol Int; 2002 Oct; 69(4):273-7. PubMed ID: 12444282
    [Abstract] [Full Text] [Related]

  • 27. Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506.
    Ishii H, Furuse J, Boku N, Okusaka T, Ikeda M, Ohkawa S, Fukutomi A, Hamamoto Y, Nakamura K, Fukuda H, JCOG Gastrointestinal Oncology Study Group.
    Jpn J Clin Oncol; 2010 Jun; 40(6):573-9. PubMed ID: 20185458
    [Abstract] [Full Text] [Related]

  • 28. Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial.
    Sakamoto H, Kitano M, Suetomi Y, Takeyama Y, Ohyanagi H, Nakai T, Yasuda C, Kudo M.
    J Gastroenterol; 2006 Jan; 41(1):70-6. PubMed ID: 16501860
    [Abstract] [Full Text] [Related]

  • 29. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
    Bukowski RM, Abderhalden RT, Hewlett JS, Weick JK, Groppe CW.
    Cancer Clin Trials; 1980 Jan; 3(4):321-4. PubMed ID: 6448716
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A new method of intra-arterial regional chemotherapy with more selective drug delivery for locally advanced pancreatic cancer.
    Ohigashi H, Ishikawa O, Imaoka S, Sasaki Y, Kabuto T, Kameyama M, Furukawa H, Hiratuka M, Nakamori S, Nakano H, Yasuda T, Iwanaga T.
    Hepatogastroenterology; 1996 Jan; 43(8):338-45. PubMed ID: 8714226
    [Abstract] [Full Text] [Related]

  • 32. Pancreatic cancer treated with carmustine, fluorouracil, and spironolactone: a randomized study.
    Stephens RL, Hoogstraten B, Haas C, Clark G.
    Arch Intern Med; 1978 Jan; 138(1):115-7. PubMed ID: 619817
    [Abstract] [Full Text] [Related]

  • 33. Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group.
    Cancer Treat Rep; 1985 Apr; 69(4):417-20. PubMed ID: 2859924
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Compassionate use of Gemzar in advanced pancreatic cancer: a Belgian experience.
    Humblet Y, Van Cutsem E, Dubois C, Gillard P.
    Acta Gastroenterol Belg; 2001 Apr; 64(4):305-8. PubMed ID: 11887632
    [Abstract] [Full Text] [Related]

  • 36. Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma. A Mid-Atlantic Oncology Program study.
    Rothman H, Cantrell JE, Lokich J, Difino S, Harvey J, Ahlgren J, Fryer J.
    Cancer; 1991 Jul 15; 68(2):264-8. PubMed ID: 2070323
    [Abstract] [Full Text] [Related]

  • 37. Phase II trial of Virulizin in patients with pancreatic cancer.
    Warner E, Weinroth J, Chang S, MacDonald M, Strauss B.
    Clin Invest Med; 1994 Feb 15; 17(1):37-41. PubMed ID: 8174313
    [Abstract] [Full Text] [Related]

  • 38. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
    Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC.
    Nutr Cancer; 2000 Feb 15; 36(2):177-84. PubMed ID: 10890028
    [Abstract] [Full Text] [Related]

  • 39. A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A Southwest Oncology Group study.
    Morrell LM, Bach A, Richman SP, Goodman P, Fleming TR, MacDonald JS.
    Cancer; 1991 Jan 15; 67(2):363-6. PubMed ID: 1985731
    [Abstract] [Full Text] [Related]

  • 40. [Isolated hypoxic perfusion with mitomycin C confers no benefit for patients with advanced pancreatic carcinoma].
    Petrowsky H, Heinrich S, Staib-Sebler E, Gog C, Janshon G, Lorenz M.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Jan 15; 115():1351-3. PubMed ID: 9931879
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.